Skip to main content
Premium Trial:

Request an Annual Quote

Icoria Unit to Sell miRNA Arrays Made by Rosetta Genomics

NEW YORK, Oct. 15 (GenomeWeb News) - A unit of Icoria will exclusively sell Rosetta Genomics' MirChip microRNA detection and analysis services, the companies said today.


Icoria's Paradigm Array Labs business unit will commercialize the service, which will be launched Oct. 26 at the American Society of Human Genetics conference in Toronto, the firms said.

Financial details of the deal were not disclosed.

Icoria, which used to be Paradigm Genetics, is an authorized service provider for Affymetrix and Agilent gene expression-analysis platforms.


Rosetta Genomics is based in Rehovot, Israel.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.